ITEOS THERAPEUTICS INC (ITOS) Stock Income Statement
USA - NASDAQ:ITOS - US46565G1040 - Common Stock
10.15 USD
+0.02 (+0.2%)
10.17 USD
+0.02 (+0.2%)
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 35.00M | 12.60M | 267.60M | 344.80M | 0 | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 194.53M | 163.70M | 141.30M | 99.90M | 45.20M | |||
| Research and Development | 145.45M | 113.30M | 97.40M | 59.40M | 29.90M | |||
| Selling, General, and Administrative Expenses | 49.08M | 50.40M | 43.90M | 40.50M | 15.30M | |||
| Operating Income | -159.53M | -151.10M | 126.30M | 244.90M | -45.20M | |||
| Interest Income/Expense | 30.87M | 31.77M | 11.40M | null | null | |||
| Other Income/Expense | 8.31M | 10.30M | 11.10M | 11.60M | 7.20M | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | -120.34M | -109.03M | 148.70M | 256.50M | -38.10M | |||
| Income Tax | 14.07M | 3.61M | 52.10M | 41.90M | -100.00K | |||
| Net Income | -134.41M | -112.64M | 96.70M | 214.50M | -43.40M | |||
| EBITDA | -158.29M | -150.20M | 127.10M | 245.50M | -44.70M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.321 | -3.1496 | 2.56 | 5.68 | -1.24 | |||
| Non GAAP EPS | -3.33 | -3.15 | null | 5.61 | null | |||
| Statistics | ||||||||
| Profit Margin | -384.04% | -894.34% | 36.14% | 62.21% | N/A | |||
| Operating Profit Margin | -455.79% | -1199.69% | 47.20% | 71.03% | N/A | |||
All data in USD